336 related articles for article (PubMed ID: 25514497)
1. Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection.
Lavoisier A; Schlaeppi JM
MAbs; 2015; 7(1):77-83. PubMed ID: 25514497
[TBL] [Abstract][Full Text] [Related]
2. A novel screening method to assess developability of antibody-like molecules.
Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA
MAbs; 2015; 7(4):752-8. PubMed ID: 25961854
[TBL] [Abstract][Full Text] [Related]
3. Size-based characterization of nanoparticle mixtures by the inline coupling of capillary electrophoresis to Taylor dispersion analysis.
Oukacine F; Morel A; Desvignes I; Cottet H
J Chromatogr A; 2015 Dec; 1426():220-5. PubMed ID: 26653841
[TBL] [Abstract][Full Text] [Related]
4. A nanolitre method to determine the hydrodynamic radius of proteins and small molecules by Taylor dispersion analysis.
Hulse WL; Forbes RT
Int J Pharm; 2011 Jun; 411(1-2):64-8. PubMed ID: 21440611
[TBL] [Abstract][Full Text] [Related]
5. An accelerated surface-mediated stress assay of antibody instability for developability studies.
Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
[TBL] [Abstract][Full Text] [Related]
7. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
8. Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates.
Hawe A; Hulse WL; Jiskoot W; Forbes RT
Pharm Res; 2011 Sep; 28(9):2302-10. PubMed ID: 21560019
[TBL] [Abstract][Full Text] [Related]
9. Analysis of antibody self-interaction by bio-layer interferometry as tool to support lead candidate selection during preformulation and developability assessments.
Domnowski M; Hackner B; Neuber T; Jaehrling J; Frieß W
Int J Pharm; 2020 Nov; 589():119854. PubMed ID: 32898632
[TBL] [Abstract][Full Text] [Related]
10. Hydrodynamic size characterization of a self-emulsifying lipid pharmaceutical excipient by Taylor dispersion analysis with fluorescent detection.
Chamieh J; Jannin V; Demarne F; Cottet H
Int J Pharm; 2016 Nov; 513(1-2):262-269. PubMed ID: 27620340
[TBL] [Abstract][Full Text] [Related]
11. Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
Bailly M; Mieczkowski C; Juan V; Metwally E; Tomazela D; Baker J; Uchida M; Kofman E; Raoufi F; Motlagh S; Yu Y; Park J; Raghava S; Welsh J; Rauscher M; Raghunathan G; Hsieh M; Chen YL; Nguyen HT; Nguyen N; Cipriano D; Fayadat-Dilman L
MAbs; 2020; 12(1):1743053. PubMed ID: 32249670
[TBL] [Abstract][Full Text] [Related]
12. A Taylor dispersion analysis method for the sizing of therapeutic proteins and their aggregates using nanolitre sample quantities.
Hulse W; Forbes R
Int J Pharm; 2011 Sep; 416(1):394-7. PubMed ID: 21745555
[TBL] [Abstract][Full Text] [Related]
13. Size-based characterization by the coupling of capillary electrophoresis to Taylor dispersion analysis.
Saux TL; Cottet H
Anal Chem; 2008 Mar; 80(5):1829-32. PubMed ID: 18247486
[TBL] [Abstract][Full Text] [Related]
14. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the inter and intra batch variability of protein aggregation behaviour using Taylor dispersion analysis and dynamic light scattering.
Hulse WL; Gray J; Forbes RT
Int J Pharm; 2013 Sep; 453(2):351-7. PubMed ID: 23751342
[TBL] [Abstract][Full Text] [Related]
16. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y
MAbs; 2015; 7(3):553-61. PubMed ID: 25790175
[TBL] [Abstract][Full Text] [Related]
17. Developability assessment during the selection of novel therapeutic antibodies.
Jarasch A; Koll H; Regula JT; Bader M; Papadimitriou A; Kettenberger H
J Pharm Sci; 2015 Jun; 104(6):1885-1898. PubMed ID: 25821140
[TBL] [Abstract][Full Text] [Related]
18. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
Baek Y; Singh N; Arunkumar A; Zydney AL
Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Structural Integrity and Stability Using Nanograms of Protein by Flow-Induced Dispersion Analysis.
Pedersen ME; Østergaard J; Jensen H
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458703
[TBL] [Abstract][Full Text] [Related]
20. Rapid determination of hydrodynamic radii beyond the limits of Taylor dispersion.
Latunde-Dada S; Bott R; Crozier J; Trikeriotis M; Leszczyszyn OI; Goodall D
J Chromatogr A; 2016 Nov; 1472():66-73. PubMed ID: 27773390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
